10-07-2011: Epistem announced the formation of a human DNA Identification collaboration with the National Policing Improvement Agency (NPIA). Epistem and the NPIA will be evaluating Epistem’s Genedrive™ molecular device as part of the NPIA’s ADAPT programme (Accelerated DNA Profiling Technology programme).

The NPIA provides critical national services to support frontline policing. It helps the police to save money and operate more efficiently. The NPIA will use Genedrive™ to target the ‘amelogenin’ sex gene and other single tandem repeats (STRs) that create the human DNA fingerprint. If trials are successful, the NPIA could use Genedrive™ to enable rapid and accurate DNA analysis at a crime scene leading to improved speed of identification, reduced cost and more efficient policing leading to a safer environment.

Contact / Request information

Request further information free of charge:

Facts, background information, dossiers
  • EpiStem
  • deoxyribonucleic acid
More about EpiStem
  • News

    Epistem: Human Deoxyribonucleic acid (DNA) Identification collaboration

    Epistem announced the formation of a human DNA Identification collaboration with the National Policing Improvement Agency (NPIA). Epistem and the NPIA will be evaluating Epistem’s Genedrive™ molecular device as part of the NPIA’s ADAPT programme (Accelerated DNA Profiling Technology program ... more

    Epistem Announces Tuberculosis Diagnostic Collaboration

    Epistem plc announced the formation of a Tuberculosis (TB) diagnostic collaboration with Xcelris Laboratories, one of India's Genomics research and Diagnostic testing companies. Epistem and Xcelris will be evaluating Epistem's Genedrive(TM) molecular device as part of India's RNTCP (Revised ... more

    Epistem Announces Collaboration With sanofi-aventis

    Epistem plc  announced a collaboration with sanofi-aventis U.S. Inc. relating to the use of Epistem's proprietary biomarker gene expression profiling and immunohistochemistry technologies. Under the terms of the agreement sanofi-aventis has entered into a 3 year collaboration with Epistem t ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE